Aqr Capital Management LLC Kempharm, Inc Transaction History

Aqr Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.02 - $5.21 $413,091 - $535,374	-102,759 Reduced 48.91%	107,341 $479,000
Q1 2022 May 16, 2022	BUY	$5.0 - $9.26 $748,340 - $1.39 Million	149,668 Added 247.66%	210,100 $1.06 Million
Q4 2021 Feb 14, 2022	SELL	$7.6 - $10.26 $306,872 - $414,278	-40,378 Reduced 40.05%	60,432 $526,000
Q3 2021 Nov 15, 2021	BUY	$8.72 - $13.31 $879,063 - $1.34 Million	100,810 New	100,810 $941,000

116

26.1M

591K

242K

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.